CLINICAL_TRIALS trial_result · 2025-06-15

Clinical Trial Update: LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies

This clinical trial evaluated whole genome sequencing as a first-line diagnostic tool for leukodystrophies, with results posted in 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Children's Hospital of Philadelphia | Conditions: Leukodystrophy, White Matter Disease | Status: COMPLETED | Results posted: 2025-06-15